Binder CJ - Search Results

1

A diet-induced hypercholesterolemic murine model to study atherogenesis without obesity and metabolic syndrome.

Hartvigsen K, Binder CJ, Hansen LF, Rafia A, Juliano J, Hörkkö S, Steinberg D, Palinski W, Witztum JL, Li AC. Hartvigsen K, et al. Among authors: binder cj. Arterioscler Thromb Vasc Biol. 2007 Apr;27(4):878-85. doi: 10.1161/01.ATV.0000258790.35810.02. Epub 2007 Jan 25. Arterioscler Thromb Vasc Biol. 2007. PMID: 17255537

2

Innate and acquired immunity in atherogenesis.

Binder CJ, Chang MK, Shaw PX, Miller YI, Hartvigsen K, Dewan A, Witztum JL. Binder CJ, et al. Nat Med. 2002 Nov;8(11):1218-26. doi: 10.1038/nm1102-1218. Nat Med. 2002. PMID: 12411948 Review. No abstract available.

3

Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL.

Binder CJ, Hörkkö S, Dewan A, Chang MK, Kieu EP, Goodyear CS, Shaw PX, Palinski W, Witztum JL, Silverman GJ. Binder CJ, et al. Nat Med. 2003 Jun;9(6):736-43. doi: 10.1038/nm876. Epub 2003 May 12. Nat Med. 2003. PMID: 12740573

4

IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis.

Binder CJ, Hartvigsen K, Chang MK, Miller M, Broide D, Palinski W, Curtiss LK, Corr M, Witztum JL. Binder CJ, et al. J Clin Invest. 2004 Aug;114(3):427-37. doi: 10.1172/JCI20479. J Clin Invest. 2004. PMID: 15286809 Free PMC article.

5

Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma.

Li AC, Binder CJ, Gutierrez A, Brown KK, Plotkin CR, Pattison JW, Valledor AF, Davis RA, Willson TM, Witztum JL, Palinski W, Glass CK. Li AC, et al. Among authors: binder cj. J Clin Invest. 2004 Dec;114(11):1564-76. doi: 10.1172/JCI18730. J Clin Invest. 2004. PMID: 15578089 Free PMC article.

6

The role of natural antibodies in atherogenesis.

Binder CJ, Shaw PX, Chang MK, Boullier A, Hartvigsen K, Hörkkö S, Miller YI, Woelkers DA, Corr M, Witztum JL. Binder CJ, et al. J Lipid Res. 2005 Jul;46(7):1353-63. doi: 10.1194/jlr.R500005-JLR200. Epub 2005 May 16. J Lipid Res. 2005. PMID: 15897601 Free article. Review.

7

Inhibition of the renin-angiotensin system abolishes the proatherogenic effect of uremia in apolipoprotein E-deficient mice.

Bro S, Binder CJ, Witztum JL, Olgaard K, Nielsen LB. Bro S, et al. Among authors: binder cj. Arterioscler Thromb Vasc Biol. 2007 May;27(5):1080-6. doi: 10.1161/ATVBAHA.107.139634. Epub 2007 Mar 8. Arterioscler Thromb Vasc Biol. 2007. PMID: 17347482

8

Natural antibodies in murine atherosclerosis.

Binder CJ, Chou MY, Fogelstrand L, Hartvigsen K, Shaw PX, Boullier A, Witztum JL. Binder CJ, et al. Curr Drug Targets. 2008 Mar;9(3):190-5. doi: 10.2174/138945008783755520. Curr Drug Targets. 2008. PMID: 18336236 Review.

9

The role of innate immunity in atherogenesis.

Hartvigsen K, Chou MY, Hansen LF, Shaw PX, Tsimikas S, Binder CJ, Witztum JL. Hartvigsen K, et al. Among authors: binder cj. J Lipid Res. 2009 Apr;50 Suppl(Suppl):S388-93. doi: 10.1194/jlr.R800100-JLR200. Epub 2008 Dec 22. J Lipid Res. 2009. PMID: 19106070 Free PMC article. Review.

10

Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans.

Chou MY, Fogelstrand L, Hartvigsen K, Hansen LF, Woelkers D, Shaw PX, Choi J, Perkmann T, Bäckhed F, Miller YI, Hörkkö S, Corr M, Witztum JL, Binder CJ. Chou MY, et al. Among authors: binder cj. J Clin Invest. 2009 May;119(5):1335-49. doi: 10.1172/JCI36800. Epub 2009 Apr 13. J Clin Invest. 2009. PMID: 19363291 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

219 results

Search Page